Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 18/20 | 0.42 |
| ▸ | PPARA | Q07869 | 16/20 | 0.42 |
| ▸ | PPARG | P37231 | 15/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 7/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 7/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.37 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8666064 | 0.76 | PPARD (0.44) | PPARDPPARAPPARGNR1H2NR1H3 | |
| SCHEMBL7040442 | 0.75 | PPARA (0.52) | PPARDPPARAPPARG | |
| SCHEMBL7046131 | 0.75 | PPARG (0.73) | PPARDPPARAPPARGNR1H2NR1H3 | |
| SCHEMBL8443121 | 0.75 | KDM1A (0.43) | PPARDPPARAPPARGNR1H2NR1H3 | |
| SCHEMBL6559946 | 0.75 | PPARD (0.72) | PPARDPPARAPPARGNR1H2NR1H3 | |
| SCHEMBL6932993 | 0.73 | PPARG (0.49) | PPARDPPARAPPARGLTB4RLTB4R2 | |
| SCHEMBL7039181 | 0.72 | PPARD (0.62) | PPARDPPARAPPARGNR1H2NR1H3 | |
| SCHEMBL7040305 | 0.72 | NR1H3 (0.81) | PPARDPPARAPPARGNR1H2NR1H3 | |
| SCHEMBL7044750 | 0.70 | PPARD (0.59) | PPARDPPARAPPARGNR1H2NR1H3 | |
| SCHEMBL6559367 | 0.69 | PPARG (0.47) | PPARDPPARAPPARGNR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0882029-B1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO INC (US) | 2003-04-02 | — | — | EP | claimed |
| EP-0882029-B1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO INC (US) | 2003-04-02 | — | — | EP | disclosed |
| US-6090836-A | DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION | MERCK & CO., INC. (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0882029-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | Merck & Co., Inc. (US) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997028137-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | disclosed |